Literature DB >> 12393638

Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.

Holger Hebart1, Claudia Bollinger, Paul Fisch, Jacqueline Sarfati, Christoph Meisner, Manuela Baur, Jürgen Loeffler, Michel Monod, Jean-Paul Latgé, Hermann Einsele.   

Abstract

Invasive aspergillosis has become a major cause of infection-related mortality in nonneutropenic patients after allogeneic stem cell transplantation (SCT). To assess the potential role of Aspergillus-specific T-cell responses for the successful control of invasive aspergillosis, lymphoproliferative responses to Aspergillus fumigatus antigens were studied in healthy individuals, patients with evidence of invasive aspergillosis, and patients late after allogeneic SCT. In healthy individuals, a positive lymphoproliferative response was documented to cellular extracts of A fumigatus (14 of 16), the 88-kDa dipeptidylpeptidase (4 of 16), and the 90-kDa catalase (8 of 11). A predominant release of interferon gamma (IFN-gamma) in culture supernatants on stimulation with A fumigatus antigens was demonstrated in 13 of 17 healthy individuals, indicating a T(H)1 response. In patients with clinical evidence of invasive aspergillosis, a favorable response to antifungal therapy was found to correlate with a higher IFN-gamma/interleukin 10 (IL-10) ratio in culture supernatants (n = 7; median ratio, IFN-gamma/IL-10 = 1.0; range, 0.09-24.8) compared to 10 patients with progressive or stable disease (median ratio, IFN-gamma/IL-10 = 0.1; range, 0.002-2.1; P =.04). Steroid treatment was found to suppress Aspergillus-specific lymphoproliferation (P =.037) and release of IFN-gamma in culture supernatants (P =.017). In contrast to cytomegalovirus- and tetanus toxoid-specific T-cell responses, Aspergillus-specific T-cell reconstitution late after allogeneic SCT was characterized by low stimulation indices and a low IFN-gamma/IL-10 ratio. In addition, phosphoantigen-reactive V(gamma)9/V(delta)2 T-cell clones from healthy individuals were found to produce significant amounts of tumor necrosis factor in response to A fumigatus antigens. In conclusion, these results further support the hypothesis that T cells contribute to the host defense against A fumigatus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393638     DOI: 10.1182/blood-2002-01-0265

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

Review 1.  Specific infectious complications after stem cell transplantation.

Authors:  Holger Hebart; Hermann Einsele
Journal:  Support Care Cancer       Date:  2003-08-15       Impact factor: 3.603

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

Authors:  Katia Perruccio; Antonella Tosti; Emanuela Burchielli; Fabiana Topini; Loredana Ruggeri; Alessandra Carotti; Marusca Capanni; Elena Urbani; Antonella Mancusi; Franco Aversa; Massimo F Martelli; Luigina Romani; Andrea Velardi
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

Review 4.  Aspergillus fumigatus: principles of pathogenesis and host defense.

Authors:  Tobias M Hohl; Marta Feldmesser
Journal:  Eukaryot Cell       Date:  2007-09-21

5.  Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Andrew B Shreiner; Roderick A McDonald; John J Osterholzer; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

6.  A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states.

Authors:  Julie M Steinbrink; Aimee K Zaas; Marisol Betancourt; Jennifer L Modliszewski; David L Corcoran; Micah T McClain
Journal:  Transl Res       Date:  2020-02-20       Impact factor: 7.012

7.  Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

Authors:  Louis Y A Chai; Frank van de Veerdonk; Renoud J Marijnissen; Shih-Chin Cheng; Ai Leng Khoo; Magda Hectors; Katrien Lagrou; Alieke G Vonk; Johan Maertens; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

8.  Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.

Authors:  Stacy J Park; Molly A Hughes; Marie Burdick; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis.

Authors:  Leonardo Potenza; Patrizia Barozzi; Giulio Rossi; Giovanni Palazzi; Daniela Vallerini; Giovanni Riva; Monica Cellini; Monica Morselli; Francesco Volzone; Claudia Venturelli; Chiara Quadrelli; Luciana Di Pancrazio; Maria Carmen Cano; Paolo Paolucci; Giuseppe Torelli; Mario Luppi
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

10.  Healthy human T-Cell Responses to Aspergillus fumigatus antigens.

Authors:  Neelkamal Chaudhary; Janet F Staab; Kieren A Marr
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.